2Martin N, Catalin J, Blachon MF, et al. Assay of paclitaxel (Taxol) in plasma and urine by high-performance liquid chromatography. J Chromatogr B Biomed Sci Appl, 1998, 709: 281-288.
3Ciccolini J, Catalin J, Blachon MF, et al. Rapid high- performance liquid chromatographic determination of docetaxel (Taxotere) in plasma using liquid-liquid extraction. J Chromatogr B Biomed Sci Appl, 2001, 759: 299-306.
4Ginnai L, Kearns CM, Ginai A, et al. Nonlinear pharmacokinetics and metabolism of paclitaxel and its pharmacokinetic/pharmacodynamic relationships in humans [J]. J Clin Oncol, 1995,13 ( 1 ) : 180 - 190.
5Holmes AF, Mdadent T, Nemwna RA, et al. Sequence-dependent alteration of doxorubicin in phmaracokinetics by paclitaxel in a phasa I study of paclitaxel and doxorubicin in patients with metastatic breast cancer [ J ]. J Clin Oncol, 1996,14 (10) :2713 - 2721.
6Joerger M, Alwin D. R. Huitema, Desiree H. J. G. van den Bongard, et al. Quantitative Effect of Gender,Age, Liver Function, and Body Size on the Population Pharmacokinetics of Paclitaxel in Patients with Solid Tumors [ J ]. Clin Cancer Res, 2006,12:2150 - 2157.
7Huizing MT, Giaccone G,Van Warmerdam LJ, et al. Pharmacokinetics of paclitaxel and carboplatin in a dose-escalating and dose-sequencing study in patients with non-small-cell lung cancer [ J ]. J Clin Oncol, 1997,15 ( 1 ) :317 - 329.
8Henningsson A, Karlsson MO, Vignao L, et al. Mechanism-based pharmacokinetic model for paelitxael [ J ]. J Clin Oncol, 2001,19 (20) :4065 -4073.
9Ichiki M, Gohara R, Fujiki R, et al. Phasel and phmaracokinetic study of carboplatin and paclixatel with a biweekly sehedule in patients with advanced non-small-cell lung cancer [ J ]. Cancer Chemother and Pharmacol,2003,52 ( 1 ) : 67 - 72.
10Huizing MT, Keung AC, Rosing H, et al. Pharmacokinetics of paclitaxel and metabolism in a randomized comparative study in platinum -pretreated ovarian cancer patiant [ J ]. J Clin Oncol, 1993,11 (11 ) : 2127.
